Evidence map›Paper›PMID 32668585›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Antimicrobial Susceptibility and Characterization of Resistance Mechanisms of

Itziar Chapartegui-González, Marta Fernández-Martínez, Ana Rodríguez-Fernández, Danilo J P Rocha, Eric R G R Aguiar, Luis G C Pacheco, José Ramos-Vivas, Jorge Calvo, Luis Martínez-Martínez, Jesús Navas

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evaluation of omadacyclineAntimicrobial agents and chemotherapy · 2025
    Article
  5. New microbes and new infections · 2025
    Article
  6. [Emergent presence of slow-growing microorganisms in urine cultures. Clinical and microbiological analysis].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Article
  7. ThePeerJ · 2025
    Review
  8. Article
  9. Multidrug-resistant toxigenicMicrobial genomics · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Pathogens (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Genetic Resistance Determinants in ClinicalAntibiotics (Basel, Switzerland) · 2022
    Article
  16. In vitro Studies of Non-DiphtheriaeInfection and drug resistance · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Itziar Chapartegui-GonzálezGrupo BIOMEDAGE, Facultad de Medicina, Universidad de Cantabria, Herrera Oria 2, 39011 Santander, Spain.ORCID 0000-0001-7878-4499
Marta Fernández-MartínezInstituto de Investigación Valdecilla (IDIVAL), Herrera Oria s/n, 39011 Santander, Spain.
Ana Rodríguez-FernándezServicio de Microbiología, Hospital Universitario Marqués de Valdecilla (HUMV), Av. Valdecilla, 25, 39008 Santander, Spain.
Danilo J P RochaInstituto de Ciências da Saúde, Universidade Federal da Bahia, Av. Reitor Miguel Calmon, s/n -Canela, Salvador 40231-300, Brasil.
Eric R G R AguiarDepartment of Biological Sciences, Center of Biotechnology and Genetics, State University of Santa Cruz (UESC), Ilhéus 45662-90, Brazil.ORCID 0000-0002-8143-5756
Luis G C PachecoInstituto de Ciências da Saúde, Universidade Federal da Bahia, Av. Reitor Miguel Calmon, s/n -Canela, Salvador 40231-300, Brasil.
José Ramos-VivasInstituto de Investigación Valdecilla (IDIVAL), Herrera Oria s/n, 39011 Santander, Spain.ORCID 0000-0001-8795-519X
Jorge CalvoInstituto de Investigación Valdecilla (IDIVAL), Herrera Oria s/n, 39011 Santander, Spain.
Luis Martínez-MartínezUnidad de Gestión Clínica, Hospital Universitario Reina Sofía, Av. Menéndez Pidal, s/n, 14004 Córdoba, Spain.
Jesús NavasGrupo BIOMEDAGE, Facultad de Medicina, Universidad de Cantabria, Herrera Oria 2, 39011 Santander, Spain.ORCID 0000-0001-5735-4668
Marqués de Valdecilla University Hospital · ESUniversidad de Cantabria · ESUniversidade Federal da Bahia · BRInstituto de Investigación Marqués de Valdecilla · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversidade Estadual de Santa Cruz · BR

Funding

Instituto de Salud Carlos III D16/0016/0007Instituto de Salud Carlos III RD16/0016/0008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobialsCorynebacterium urealyticumcoryneformmultidrug resistancewhole genome sequencing

Identifiers

PMID32668585
PMCPMC7400432
OpenAlexW3041453287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.